Fumito Ito

General Surgery

1450 San Pablo St Ste 6200
Los Angeles, CA 90033

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Correction: ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.

Correction: ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.

Journal: Annals of surgical oncology

Published: September 05, 2026

Correction: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.

Correction: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.

Journal: Annals of surgical oncology

Published: September 04, 2026

ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.

ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.

Journal: Annals of surgical oncology

Published: July 31, 2026

ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.

ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.

Journal: Annals of surgical oncology

Published: July 31, 2026

Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.

Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.

Journal: Annals of surgical oncology

Published: April 28, 2026

Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.

Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.

Journal: Annals of surgical oncology

Published: April 28, 2026

Risk-reducing gynecologic surgery decisions in Lynch syndrome at a safety-net hospital and university medical center.

Risk-reducing gynecologic surgery decisions in Lynch syndrome at a safety-net hospital and university medical center.

Journal: Gynecologic oncology

Published: March 02, 2026

Inflammaging in melanoma: Precision control for optimizing immune checkpoint inhibition.

Inflammaging in melanoma: Precision control for optimizing immune checkpoint inhibition.

Journal: Journal of dermatological science

Published: February 19, 2026

Dual-edged therapy: corticosteroids in the era of immunotherapy.

Dual-edged therapy: corticosteroids in the era of immunotherapy.

Journal: Immunotherapy

Published: January 20, 2026

Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy.

Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy.

Journal: Nature communications

Published: November 28, 2025

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

Journal: Journal for immunotherapy of cancer

Published: October 29, 2025

Facilitators and Barriers to the Timely Diagnosis and Treatment of Melanoma in Latino Persons.

Facilitators and Barriers to the Timely Diagnosis and Treatment of Melanoma in Latino Persons.

Journal: JAMA dermatology

Published: October 01, 2025

Showing 1-12 of 54

Last Updated: 09/26/2026